Combined Examination of P27(kip1), P21(waf1/cip1) and P53 Expression Allows Precise Estimation of Prognosis in Patients with Gastric Carcinoma.

XP Liu,S Kawauchi,A Oga,Y Suehiro,K Tsushimi,M Tsushimi,K Sasaki
DOI: https://doi.org/10.1046/j.1365-2559.2001.01283.x
2001-01-01
Histopathology
Abstract:Aims: In order to estimate the prognostic values of p27(Kip1), p21(Waf1/Cip1), and p53, alone and in combination, we investigated immunohistochemically the expression of p27(Kip1), p21(Waf1/Cip1), and p53 proteins in gastric carcinomas.Methods and results: The expression of p27(Kip1), p21(Waf1/Cip1), and p53 was immunohistochemically examined in 140 gastric carcinomas. Positive expression of P27(Kip1) and p21(Waf1/Cip1) correlated significantly with a favourable prognosis (P<0.05), whereas, positive expression of p53 tended to correlate with poor prognosis. Multivariate survival analysis revealed that TNM stage of tumour (P<0.001), lymph node state (P=0.005), and p27(Kip1) expression (P=0.006) were independent prognostic factors. A striking stratification of mortality rate was found when patients were divided into four groups according to the expression of p21(Waf1/Cip1) and p27(Kip1). The mortality rate was higher in patients with both p21(Waf1/Cip1)- and p27(Kip1)-negative gastric carcinoma than in patients with one or both positive carcinomas (P<0.01). In addition, if the four p21(Waf1/Cip1)/p27(Kip1) groups were compared based on p53 status, p53+ cases tended to have a higher mortality rate than p53-cases.Conclusion: Our results suggest that low expression of both p27(Kip1) and p21(Waf1/Cip1) could be useful as markers of poorer prognosis, and the combined examination of P27(Kip1), p21(Waf1/Cip1) and p53 expression allows reliable estimation of prognosis for patients with gastric carcinoma.
What problem does this paper attempt to address?